Sino Biopharmaceutical Jumps After Cancer Drug Deal With Boehringer
Shares of Sino Biopharmaceutical jumped after a cancer drug deal with Boehringer.
Related stories
Japanese Stocks Rally, While AI and Chip Shares Extend Declines
Japanese stocks rallied Thursday as crude oil fell after US midterm elections, while AI and chip shares extended declines from Wednesday.
M impact | EQUITY | Nov 05, 2026, 02:30 AM UTC
Japan Stocks Rise as AI Shares Extend Their Decline
Japanese stocks mostly rose, while AI-related shares extended their decline.
M impact | EQUITY | Nov 05, 2026, 02:23 AM UTC
Hipages Group Shares Hit One-Month Low on Weak Forecast
Shares of Australia's Hipages Group hit a more than one-month low after a weak forecast.
M impact | EQUITY | Nov 05, 2026, 02:20 AM UTC
Centrus Energy reports quarterly results for period ended September 30
M impact | EQUITY | Nov 05, 2026, 02:20 AM UTC
South Korean Shares Fall as Chipmakers Track US Tech Slump
South Korean shares fell sharply, with the KOSPI down 227.68 points, as chipmakers tracked overnight losses in US technology stocks.
M impact | EQUITY | Nov 05, 2026, 02:20 AM UTC
CS Wind Wins $59.47 Million Wind Tower Supply Contract
CS Wind won a USD 59.47 million wind tower supply contract with Vestas American Wind Technology.
M impact | EQUITY | Nov 05, 2026, 02:16 AM UTC